Rebecca Brunette is Associate Director, Product Sciences & Characterization. Rebecca is an Immunologist by training and received her B.S. in Microbiology and then her Ph.D. in Immunology both from the University of Washington. Prior to joining GentiBio, Rebecca worked on CAR-T and TCR cell therapy development at Juno/Celgene/Bristol Myers Squibb. She held several positions with increasingly responsibilities in the Analytical Development group first as a Scientist and then leader of the flow cytometry method development team supporting both product release and characterization. At Juno/Celgene/ Bristol Myers Squibb she also served as an Analytical Development Strategy Lead for a pivotal phase autologous CAR-T program and an early phase allogeneic CAR-T program. Prior to her experience in cell therapy development Rebecca was a Scientist on the Discovery Biology team at Silverback Therapeutics screening, validating and performing mechanism studies for immuno-stimulatory antibody-small molecule conjugates targeting tumors. Rebecca enjoys going to the beach, hiking and skiing with her husband and daughters in her free time.
Rebecca Brunette, PhD
Associate Director, Product Sciences and Characterization
